Article in Radiology. Artificial intelligence, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Felix Busch *From the Department of Radiology (F.B., L.H., S.M.N.), Department of Anesthesiology, Division of Operative Intensive Care Medicine (F.B.), Department of Cardiology (P.S.), and Department of Rheumatology (K.B.B., D.P., A.Z.), Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, 12203 Berlin, Germany; Department of Radiology and Nuclear Medicine, German Heart Center, Technical University of Munich, Munich, Germany (K.K.B.); Department of Diagnostic and Interventional Radiology, Technical University of Munich, Munich, Germany (F.B., K.K.B., M.R.M., L.C.A.); Artificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School, Boston, Mass (H.J.W.L.A.); Departments of Radiation Oncology and Radiology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Mass (H.J.W.L.A.); and Department of Radiology and Nuclear Medicine, CARIM & GROW, Maastricht University, Maastricht, the Netherlands (H.J.W.L.A.).ORCID 0000-0001-9770-8555
Keno K Bressem *From the Department of Radiology (F.B., L.H., S.M.N.), Department of Anesthesiology, Division of Operative Intensive Care Medicine (F.B.), Department of Cardiology (P.S.), and Department of Rheumatology (K.B.B., D.P., A.Z.), Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, 12203 Berlin, Germany; Department of Radiology and Nuclear Medicine, German Heart Center, Technical University of Munich, Munich, Germany (K.K.B.); Department of Diagnostic and Interventional Radiology, Technical University of Munich, Munich, Germany (F.B., K.K.B., M.R.M., L.C.A.); Artificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School, Boston, Mass (H.J.W.L.A.); Departments of Radiation Oncology and Radiology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Mass (H.J.W.L.A.); and Department of Radiology and Nuclear Medicine, CARIM & GROW, Maastricht University, Maastricht, the Netherlands (H.J.W.L.A.).ORCID 0000-0001-9249-8624
Phillip SuwalskiFrom the Department of Radiology (F.B., L.H., S.M.N.), Department of Anesthesiology, Division of Operative Intensive Care Medicine (F.B.), Department of Cardiology (P.S.), and Department of Rheumatology (K.B.B., D.P., A.Z.), Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, 12203 Berlin, Germany; Department of Radiology and Nuclear Medicine, German Heart Center, Technical University of Munich, Munich, Germany (K.K.B.); Department of Diagnostic and Interventional Radiology, Technical University of Munich, Munich, Germany (F.B., K.K.B., M.R.M., L.C.A.); Artificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School, Boston, Mass (H.J.W.L.A.); Departments of Radiation Oncology and Radiology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Mass (H.J.W.L.A.); and Department of Radiology and Nuclear Medicine, CARIM & GROW, Maastricht University, Maastricht, the Netherlands (H.J.W.L.A.).ORCID 0000-0002-2678-2595
Lena HoffmannFrom the Department of Radiology (F.B., L.H., S.M.N.), Department of Anesthesiology, Division of Operative Intensive Care Medicine (F.B.), Department of Cardiology (P.S.), and Department of Rheumatology (K.B.B., D.P., A.Z.), Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, 12203 Berlin, Germany; Department of Radiology and Nuclear Medicine, German Heart Center, Technical University of Munich, Munich, Germany (K.K.B.); Department of Diagnostic and Interventional Radiology, Technical University of Munich, Munich, Germany (F.B., K.K.B., M.R.M., L.C.A.); Artificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School, Boston, Mass (H.J.W.L.A.); Departments of Radiation Oncology and Radiology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Mass (H.J.W.L.A.); and Department of Radiology and Nuclear Medicine, CARIM & GROW, Maastricht University, Maastricht, the Netherlands (H.J.W.L.A.).ORCID 0009-0000-1374-9545
Stefan M NiehuesFrom the Department of Radiology (F.B., L.H., S.M.N.), Department of Anesthesiology, Division of Operative Intensive Care Medicine (F.B.), Department of Cardiology (P.S.), and Department of Rheumatology (K.B.B., D.P., A.Z.), Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, 12203 Berlin, Germany; Department of Radiology and Nuclear Medicine, German Heart Center, Technical University of Munich, Munich, Germany (K.K.B.); Department of Diagnostic and Interventional Radiology, Technical University of Munich, Munich, Germany (F.B., K.K.B., M.R.M., L.C.A.); Artificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School, Boston, Mass (H.J.W.L.A.); Departments of Radiation Oncology and Radiology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Mass (H.J.W.L.A.); and Department of Radiology and Nuclear Medicine, CARIM & GROW, Maastricht University, Maastricht, the Netherlands (H.J.W.L.A.).ORCID 0000-0001-6140-9385
Denis PoddubnyyFrom the Department of Radiology (F.B., L.H., S.M.N.), Department of Anesthesiology, Division of Operative Intensive Care Medicine (F.B.), Department of Cardiology (P.S.), and Department of Rheumatology (K.B.B., D.P., A.Z.), Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, 12203 Berlin, Germany; Department of Radiology and Nuclear Medicine, German Heart Center, Technical University of Munich, Munich, Germany (K.K.B.); Department of Diagnostic and Interventional Radiology, Technical University of Munich, Munich, Germany (F.B., K.K.B., M.R.M., L.C.A.); Artificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School, Boston, Mass (H.J.W.L.A.); Departments of Radiation Oncology and Radiology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Mass (H.J.W.L.A.); and Department of Radiology and Nuclear Medicine, CARIM & GROW, Maastricht University, Maastricht, the Netherlands (H.J.W.L.A.).ORCID 0000-0002-4537-6015
Marcus R MakowskiFrom the Department of Radiology (F.B., L.H., S.M.N.), Department of Anesthesiology, Division of Operative Intensive Care Medicine (F.B.), Department of Cardiology (P.S.), and Department of Rheumatology (K.B.B., D.P., A.Z.), Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, 12203 Berlin, Germany; Department of Radiology and Nuclear Medicine, German Heart Center, Technical University of Munich, Munich, Germany (K.K.B.); Department of Diagnostic and Interventional Radiology, Technical University of Munich, Munich, Germany (F.B., K.K.B., M.R.M., L.C.A.); Artificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School, Boston, Mass (H.J.W.L.A.); Departments of Radiation Oncology and Radiology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Mass (H.J.W.L.A.); and Department of Radiology and Nuclear Medicine, CARIM & GROW, Maastricht University, Maastricht, the Netherlands (H.J.W.L.A.).ORCID 0000-0002-1922-0826
Hugo J W L AertsFrom the Department of Radiology (F.B., L.H., S.M.N.), Department of Anesthesiology, Division of Operative Intensive Care Medicine (F.B.), Department of Cardiology (P.S.), and Department of Rheumatology (K.B.B., D.P., A.Z.), Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, 12203 Berlin, Germany; Department of Radiology and Nuclear Medicine, German Heart Center, Technical University of Munich, Munich, Germany (K.K.B.); Department of Diagnostic and Interventional Radiology, Technical University of Munich, Munich, Germany (F.B., K.K.B., M.R.M., L.C.A.); Artificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School, Boston, Mass (H.J.W.L.A.); Departments of Radiation Oncology and Radiology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Mass (H.J.W.L.A.); and Department of Radiology and Nuclear Medicine, CARIM & GROW, Maastricht University, Maastricht, the Netherlands (H.J.W.L.A.).ORCID 0000-0002-2122-2003
Andrei Zhukov *From the Department of Radiology (F.B., L.H., S.M.N.), Department of Anesthesiology, Division of Operative Intensive Care Medicine (F.B.), Department of Cardiology (P.S.), and Department of Rheumatology (K.B.B., D.P., A.Z.), Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, 12203 Berlin, Germany; Department of Radiology and Nuclear Medicine, German Heart Center, Technical University of Munich, Munich, Germany (K.K.B.); Department of Diagnostic and Interventional Radiology, Technical University of Munich, Munich, Germany (F.B., K.K.B., M.R.M., L.C.A.); Artificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School, Boston, Mass (H.J.W.L.A.); Departments of Radiation Oncology and Radiology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Mass (H.J.W.L.A.); and Department of Radiology and Nuclear Medicine, CARIM & GROW, Maastricht University, Maastricht, the Netherlands (H.J.W.L.A.).ORCID 0009-0009-1749-7475
Lisa C Adams *From the Department of Radiology (F.B., L.H., S.M.N.), Department of Anesthesiology, Division of Operative Intensive Care Medicine (F.B.), Department of Cardiology (P.S.), and Department of Rheumatology (K.B.B., D.P., A.Z.), Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, 12203 Berlin, Germany; Department of Radiology and Nuclear Medicine, German Heart Center, Technical University of Munich, Munich, Germany (K.K.B.); Department of Diagnostic and Interventional Radiology, Technical University of Munich, Munich, Germany (F.B., K.K.B., M.R.M., L.C.A.); Artificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School, Boston, Mass (H.J.W.L.A.); Departments of Radiation Oncology and Radiology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Mass (H.J.W.L.A.); and Department of Radiology and Nuclear Medicine, CARIM & GROW, Maastricht University, Maastricht, the Netherlands (H.J.W.L.A.).ORCID 0000-0001-5836-4542
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
Purpose To develop and evaluate a publicly available deep learning model for segmenting and classifying cardiac implantable electronic devices (CIEDs) on Digital Imaging and Communications in Medicine (DICOM) and smartphone-based chest radiographs. Materials and Methods This institutional review board-approved retrospective study included patients with implantable pacemakers, cardioverter defibrillators, cardiac resynchronization therapy devices, and cardiac monitors who underwent chest radiography between January 2012 and January 2022. A U-Net model with a ResNet-50 backbone was created to classify CIEDs on DICOM and smartphone images. Using 2321 chest radiographs in 897 patients (median age, 76 years [range, 18-96 years]; 625 male, 272 female), CIEDs were categorized into four manufacturers, 27 models, and one "other" category. Five smartphones were used to acquire 11 072 images. Performance was reported using the Dice coefficient on the validation set for segmentation or balanced accuracy on the test set for manufacturer and model classification, respectively. Results The segmentation tool achieved a mean Dice coefficient of 0.936 (IQR: 0.890-0.958). The model had an accuracy of 94.36% (95% CI: 90.93%, 96.84%; 251 of 266) for CIED manufacturer classification and 84.21% (95% CI: 79.31%, 88.30%; 224 of 266) for CIED model classification. Conclusion The proposed deep learning model, trained on both traditional DICOM and smartphone images, showed high accuracy for segmentation and classification of CIEDs on chest radiographs.
Indexed as
Deep LearningDefibrillators, ImplantableRadiography, ThoracicSmartphoneAdolescentAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedPacemaker, ArtificialRetrospective StudiesYoung AdultConventional RadiographySegmentation
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Open Access Data and Deep Learning for Cardiac Device Identification on Standard DICOM and Smartphone-based Chest Radiographs. · full record | OpenQuestion